Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
Kristen W. Cohen, Stephen C. De Rosa, William J. Fulp, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Vaccination induces broadly neutralizing antibody precursors to HIV gp41
Torben Schiffner, Ivy Phung, Rashmi Ray, et al.
Nature Immunology (2024) Vol. 25, Iss. 6, pp. 1073-1082
Open Access | Times Cited: 18
Age-related changes in the immune system and challenges for the development of age-specific vaccines
Mark Doherty, Birgit Weinberger, Arnaud M. Didierlaurent, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report
Milton Maciel, Rama Rao Amara, Katharine J. Bar, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Vaccine process technology—A decade of progress
Barry C. Buckland, Gautam Sanyal, Todd Ranheim, et al.
Biotechnology and Bioengineering (2024) Vol. 121, Iss. 9, pp. 2604-2635
Open Access | Times Cited: 7
Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 7
Adjuvant system AS01: from mode of action to effective vaccines
François Roman, Wivine Burny, Maria Angeles Ceregido, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 715-729
Open Access | Times Cited: 7
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 7
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 6
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice
Christopher A. Cottrell, Xiaozhen Hu, Jeong Hyun Lee, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 748
Open Access | Times Cited: 5
Incompletely closed HIV-1CH040 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry
Durgadevi Parthasarathy, Stephanie Pickthorn, Shamim Ahmed, et al.
npj Viruses (2025) Vol. 3, Iss. 1
Open Access
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview
Alex Boomgarden, Chitra Upadhyay
Vaccines (2025) Vol. 13, Iss. 2, pp. 148-148
Open Access
Antiviral immune responses in human reproductive tract: Pathogenic mechanisms and therapeutic implications
Kim-Ling Chin, Nurhafiza Zainal
Asian Pacific Journal of Tropical Medicine (2025) Vol. 18, Iss. 2, pp. 67-76
Open Access
Distinct binding modes drive the broad neutralization profile of two persistent influenza hemagglutinin stem-specific antibody lineages
Grace Mantus, Gabriele Cerutti, Michael Chambers, et al.
Structure (2025)
Closed Access
RNA-lipid nanoparticle therapeutics for women’s health
Alireza Nomani, Aishwarya Saraswat, Yu Zhang, et al.
Frontiers in Nanotechnology (2025) Vol. 7
Open Access
Targeting HIV persistence in the tissue
Daan K. J. Pieren, Aleix Benítez-Martínez, Meritxell Genescà
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 2, pp. 69-78
Open Access | Times Cited: 3
The D Gene in CDR H3 Determines a Public Class of Human Antibodies to SARS-CoV-2
Meng Yuan, Ian A. Wilson
Vaccines (2024) Vol. 12, Iss. 5, pp. 467-467
Open Access | Times Cited: 3
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission
Hang Su, April Mueller, Harris Goldstein
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 169-178
Closed Access | Times Cited: 3
Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses
Chuanyu Liu, Senyu Xu, Yuxuan Zheng, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114235-114235
Open Access | Times Cited: 3
DNA origami vaccines program antigen-focused germinal centers
Anna Romanov, Grant A. Knappe, Larance Ronsard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Encapsulin nanoparticle-conjugated p54 protein boosts immune responses against African swine fever virus
Yue Zhang, Yi Ru, Longhe Zhao, et al.
International Journal of Biological Macromolecules (2025), pp. 143912-143912
Closed Access
Insights from HIV-1 vaccine and passive immunization efficacy trials
Shamim Ahmed, Alon Herschhorn
Trends in Molecular Medicine (2024) Vol. 30, Iss. 10, pp. 908-912
Closed Access | Times Cited: 2
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting report
Pierre‐Stéphane Gsell, Birgitte Giersing, Sami L. Gottlieb, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7307-7312
Closed Access | Times Cited: 5
Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases
Xinglong Gao, Xinlian Wang, Shilin Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24514-24538
Closed Access | Times Cited: 5
New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement
Philip O. Buck, Aparna Gomes, Ekkehard Beck, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 234-234
Open Access | Times Cited: 1
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top